The Prognostic Value of (18)F-FDG PET/CT for Hepatocellular Carcinoma Treated with Transarterial Chemoembolization (TACE)

(18)F-Fluoro-deoxyglucose (FDG) PET/CT can be used to monitor the biological behavior of hepatocellular carcinoma (HCC). Baseline PET/CT has prognostic value in HCC patients, but there is litter knowledge of the PET/CT changes after treatment. We evaluated 27 HCC patients treated with transarterial...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Wenhui, Jia, Jia, Wang, Shengjun, Bai, Wei, Yi, Jingwei, Bai, Ming, Quan, Zhiyong, Yin, Zhanxin, Fan, Daiming, Wang, Jing, Han, Guohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038755/
https://www.ncbi.nlm.nih.gov/pubmed/24883123
http://dx.doi.org/10.7150/thno.8725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038755/
https://www.ncbi.nlm.nih.gov/pubmed/24883123
http://dx.doi.org/10.7150/thno.8725

Ejemplares similares